Kreuwel HT - Search Results

1

Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetes.

Gadkar KG, Shoda LK, Kreuwel HT, Ramanujan S, Zheng Y, Whiting CC, Young DL. Gadkar KG, et al. Among authors: kreuwel ht. Ann N Y Acad Sci. 2007 Apr;1103:63-8. doi: 10.1196/annals.1394.013. Epub 2007 Mar 21. Ann N Y Acad Sci. 2007. PMID: 17376835

2

The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.

Shoda L, Kreuwel H, Gadkar K, Zheng Y, Whiting C, Atkinson M, Bluestone J, Mathis D, Young D, Ramanujan S. Shoda L, et al. Clin Exp Immunol. 2010 Aug;161(2):250-67. doi: 10.1111/j.1365-2249.2010.04166.x. Epub 2010 May 18. Clin Exp Immunol. 2010. PMID: 20491795 Free PMC article.

3

A comprehensive review of interventions in the NOD mouse and implications for translation.

Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT. Shoda LK, et al. Among authors: kreuwel ht. Immunity. 2005 Aug;23(2):115-26. doi: 10.1016/j.immuni.2005.08.002. Immunity. 2005. PMID: 16111631 Free article. Review.

4

Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes.

Young DL, Ramanujan S, Kreuwel HT, Whiting CC, Gadkar KG, Shoda LK. Young DL, et al. Among authors: kreuwel ht. Ann N Y Acad Sci. 2006 Oct;1079:369-73. doi: 10.1196/annals.1375.057. Ann N Y Acad Sci. 2006. PMID: 17130581

5

The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes.

Zheng Y, Kreuwel HT, Young DL, Shoda LK, Ramanujan S, Gadkar KG, Atkinson MA, Whiting CC. Zheng Y, et al. Among authors: kreuwel ht. Ann N Y Acad Sci. 2007 Apr;1103:45-62. doi: 10.1196/annals.1394.014. Epub 2007 Mar 21. Ann N Y Acad Sci. 2007. PMID: 17376834

6

CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

Martinez X, Kreuwel HT, Redmond WL, Trenney R, Hunter K, Rosen H, Sarvetnick N, Wicker LS, Sherman LA. Martinez X, et al. Among authors: kreuwel ht. J Immunol. 2005 Aug 1;175(3):1677-85. doi: 10.4049/jimmunol.175.3.1677. J Immunol. 2005. PMID: 16034108

7

The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

Kreuwel HT, Sherman LA. Kreuwel HT, et al. J Clin Immunol. 2001 Jan;21(1):15-8. doi: 10.1023/a:1006780629564. J Clin Immunol. 2001. PMID: 11321233 Review.

8

Memory CD8(+) T cells undergo peripheral tolerance.

Kreuwel HT, Aung S, Silao C, Sherman LA. Kreuwel HT, et al. Immunity. 2002 Jul;17(1):73-81. doi: 10.1016/s1074-7613(02)00337-0. Immunity. 2002. PMID: 12150893 Free article.

9

Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.

Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA. Kreuwel HT, et al. J Immunol. 1999 Oct 15;163(8):4335-41. J Immunol. 1999. PMID: 10510373

10

Ontogeny of T cell tolerance to peripherally expressed antigens.

Morgan DJ, Kurts C, Kreuwel HT, Holst KL, Heath WR, Sherman LA. Morgan DJ, et al. Among authors: kreuwel ht. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3854-8. doi: 10.1073/pnas.96.7.3854. Proc Natl Acad Sci U S A. 1999. PMID: 10097127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page